The major risk of infection in cancer patients is correlated with duration and severity of chemotherapy-induced neutropenia, which depend on several factors, including the underlying disease, patient’s related characteristics, the intensity of chemotherapy, bone marrow reserve, the use of hematopoietic growth factors, and the stem cell dose in case of transplantation [1, 2].
Using rHuG-CSF in multiple myeloma: Consolidated data, Evolutions, and new concepts
Musto P.
2012-01-01
Abstract
The major risk of infection in cancer patients is correlated with duration and severity of chemotherapy-induced neutropenia, which depend on several factors, including the underlying disease, patient’s related characteristics, the intensity of chemotherapy, bone marrow reserve, the use of hematopoietic growth factors, and the stem cell dose in case of transplantation [1, 2].File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
